Key result
Fluoroless catheter ablation of cardiac arrhythmias is evaluated to determine its readiness for widespread clinical adoption.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Mansour Razminia: Consultant, Abbott. Oliver D'Silva: None.
No takes yet. Share an insight, caveat, or question.
Razminia et al. (2019) studied this question. Fluoroless catheter ablation of cardiac arrhythmias is evaluated to determine its readiness for widespread clinical adoption.
Synapse has enriched 10 related papers. Consider them for comparative context: